August Therapeutics, Inc is a biopharmaceutical company founded in 2013, dedicated to addressing intricate issues in taste receptor biology. The company focuses on pioneering new therapeutic approaches for the treatment of eating disorders and obesity. Their work spans across the biopharma, biotechnology, life sciences, and pharmaceutical sectors, aiming to make a significant impact in the field of healthcare. Although specific details regarding their headquarters, last investment, and investors are not currently available, the company's mission to revolutionize the treatment of these critical health issues is commendable, presenting significant potential for future growth and innovation in the biopharmaceutical industry.
There is no investment information
No recent news or press coverage available for August Therapeutics, Inc.
We care about your data, and we'd love to use cookies make your experience better.
